Financial Data and Key Metrics Changes - The company is in a transition phase with ongoing complexities surrounding the Ting process, which is expected to take a couple of quarters for resolution and a few quarters beyond that for full divestiture [4] - The company plans to provide 2026 guidance for each of its businesses in the Q4 earnings update in early February, which will include visibility into growth expectations [5] Business Line Data and Key Metrics Changes - The company is focusing on maximizing shareholder value in its core businesses, Domains and Wavelo, while resolving the Ting situation [4][5] - Operationally, the company is maintaining discipline, driving efficiency, and continuing to deleverage, which is expected to enhance revenue, margin, and adjusted EBITDA [6] Market Data and Key Metrics Changes - There is increased interest in the company's core businesses as it navigates the transition of Ting, indicating a potential shift in market focus [4] Company Strategy and Development Direction - Completing the Ting process is the company's top priority, which will shape its flexibility to reinvest in Domains and Wavelo and guide the next phase of growth strategy [5][6] - The company is actively preparing for future opportunities and evaluating reinvestment options to ensure readiness once the Ting process is resolved [6] Management's Comments on Operating Environment and Future Outlook - The management acknowledges the complexity of the current operating environment due to the Ting transition but remains focused on driving operational efficiency and growth [4][6] - The management is committed to keeping investors informed of any material developments as they occur [4] Other Important Information - The new CEO has a four-year fixed-term employment agreement aimed at ensuring predictability and alignment with shareholders [5] Q&A Session Summary Question: What is the timeline for the Ting process resolution? - The company anticipates that reaching a resolution could take a couple of quarters, with full divestiture likely taking a few quarters beyond that [4] Question: How should investors think about growth outlook for Domains and Wavelo during the Ting transition? - The company is looking at multiple paths to maximize shareholder value and will provide guidance for 2026 in the upcoming Q4 earnings update [5] Question: What is the strategic vision of the new CEO? - The CEO's focus is on completing the Ting process, which will directly influence the company's ability to reinvest in its core businesses [5][6]

Financial Data and Key Metrics Changes - Total revenue for Q3 2025 increased by 2.5% to $7.2 million compared to $7 million in Q3 2024 [16] - Year-to-date revenues increased by 5.6% to $20.4 million compared to $19.3 million in the first nine months of 2024 [18] - Adjusted EBITDA for Q3 2025 was $1.9 million, a 42% increase from $1.3 million in Q3 2024 [9][18] - Gross margins improved to 22.1% in Q3 2025, with a 60% year-over-year increase to $1.6 million [18] Business Line Data and Key Metrics Changes - Revenue from direct patient services increased by 9.4% to $4 million in Q3 2025, driven by increased procedures at the new facility in Puebla, Mexico [16] - Gamma Knife revenue increased by 16% year-over-year to $2.1 million in Q3 2025, with the number of procedures rising to 231 from 218 in Q3 2024 [17] - Revenue from the medical equipment leasing segment decreased to $3.1 million from $3.3 million in Q3 2024 due to lower proton beam radiation therapy volumes [16] Market Data and Key Metrics Changes - The new radiation therapy treatment center in Puebla, Mexico showed a remarkable 263% annual revenue growth [8] - The company expects continued growth in treatment volumes, particularly in Rhode Island, as new radiation oncologists engage with the healthcare community [10] Company Strategy and Development Direction - The company is transitioning from a medical equipment leasing focus to a more patient-centric service model, which is expected to enhance long-term shareholder value [4][5] - The acquisition of three Rhode Island cancer treatment centers and the new center in Puebla, Mexico are seen as significant growth opportunities [10] - Plans to construct a fourth radiation therapy center in Bristol, Rhode Island, and the first proton beam radiation therapy center in the state are underway, representing major growth opportunities [13] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the company's long-term growth strategy and the ability to weather short-term fluctuations [13] - The management team is focused on operational efficiencies and building momentum as growth strategies take hold [35] Other Important Information - The company entered Q3 2025 with cash and cash equivalents of $5.1 million, down from $11 million at the end of 2024, reflecting capital expenditures for expansion [22] - Shareholders' equity was $24.6 million, or $3.78 per outstanding share, compared to $25.2 million, or $3.92 per share at the end of 2024 [23] Q&A Session Summary Question: Concerns about shareholder value and investor outreach - A shareholder expressed concerns about the company's market cap relative to its EBITDA and suggested increased investor outreach [26] - Management acknowledged the need for more outreach and recognized the importance of communicating the company's progress to shareholders [28] Question: Disconnect between market valuation and company performance - Another investor questioned why the stock is trading at a 52-week low despite positive results and growth prospects [30] - Management attributed this to thin trading and lack of exposure, agreeing that increased outreach is necessary [32]

Core Viewpoint - The company, Steady Medical, reported a 13% year-on-year growth in the second quarter for its brand, All Cotton Era, and has seen a recovery in sales growth since July-August, continuing to pursue its annual targets [1] Group 1 - The company aims to maintain its growth trajectory by adhering to four strategic pillars: product leadership, operational excellence, brand enhancement, and a global perspective [1]